Eyenovia Stock Insider Trading

Healthcare > Biotechnology

Buy EYEN

*Your capital is at risk

$7.56

+0 (+0%)

At Close: Jan 16, 2026

Eyenovia Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 29.65M and sold 0 EYEN shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	100.00
● Buy	29.65M shares
● Sell	0 shares
100% Buy Activity Negligible or No Correlation
No Significant Signals No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date	Type	Person	Role	Amount
Apr 21, 2025 Buy	Common Stock, par value $.0001 A-Award	Strahlman Ellen R Director	Director	3 000 Value: $3K
Feb 21, 2025 Buy	Convertible Debt J-Other	Avenue Capital Management Ii, L.p. 10 Percent Owner	10% Owner	5 952 381 Value: $10.0M
Feb 21, 2025 Buy	Convertible Debt J-Other	Avenue Capital Management Ii, L.p. 10 Percent Owner	10% Owner	5 952 381 Value: $10.0M
Jan 31, 2025 Buy	Common Stock	Avenue Capital Management Ii, L.p. 10 Percent Owner	10% Owner	0 Value: $0
Jan 31, 2025 Buy	Common Stock	Avenue Capital Management Ii, L.p. 10 Percent Owner	10% Owner	0 Value: $0
Aug 30, 2024 Buy	Stock Option (right to buy) A-Award	Jones Andrew D. Chief Financial Officer	C-Suite Officer	200 000 Value: $110.0K
Aug 30, 2024 Buy	Common Stock J-Other	Jones Andrew D. Officer	Officer	0 Value: $0
Aug 30, 2024 Buy	Common Stock J-Other	Jones Andrew D. Officer	Officer	0 Value: $0
Aug 30, 2024 Buy	Stock Option (right to buy) A-Award	Jones Andrew D. Chief Financial Officer	C-Suite Officer	200 000 Value: $110.0K
Aug 28, 2024 Buy	Common Stock, par value $0.0001 P-Purchase	Rowe Michael M Chief Executive Officer	CEO / President	27 071 Value: $14.1K
Aug 28, 2024 Buy	Common Stock, par value $0.0001 P-Purchase	Rowe Michael M Chief Executive Officer	CEO / President	27 071 Value: $14.1K
Aug 26, 2024 Buy	Common Stock, par value $0.0001 P-Purchase	Rowe Michael M Chief Executive Officer	CEO / President	50 000 Value: $28.5K
Aug 26, 2024 Buy	Common Stock, par value $0.0001 P-Purchase	Rowe Michael M Chief Executive Officer	CEO / President	50 000 Value: $28.5K
Jul 02, 2024 Buy	Common stock, par value $0.0001 P-Purchase	Grant Stuart M. 10 Percent Owner	10% Owner	1 515 151 Value: $1,000.0K
Jul 02, 2024 Buy	Warrants to purchase common stock J-Other	Grant Stuart M. 10 Percent Owner	10% Owner	3 264 931 Value: $2.25M
Jul 02, 2024 Buy	Warrants to purchase common stock J-Other	Grant Stuart M. 10 Percent Owner	10% Owner	3 264 931 Value: $2.25M
Jul 02, 2024 Buy	Common stock, par value $0.0001 P-Purchase	Grant Stuart M. 10 Percent Owner	10% Owner	1 515 151 Value: $1,000.0K
Jun 12, 2024 Buy	Common Stock, par value $.0001 A-Award	Strahlman Ellen R Director	Director	61 481 Value: $3.20M
Jun 12, 2024 Buy	Stock Option (right to buy) A-Award	Strahlman Ellen R Director	Director	85 106 Value: $55.3K
Jun 12, 2024 Buy	Common Stock, par value $.0001 A-Award	Palanki Ram Director	Director	61 481 Value: $3.20M
Jun 12, 2024 Buy	Stock Option (right to buy) A-Award	Palanki Ram Director	Director	85 106 Value: $55.3K
Jun 12, 2024 Buy	Common Stock, par value $.0001 A-Award	Mather Charles E Iv Director	Director	61 481 Value: $3.20M
Jun 12, 2024 Buy	Stock Option (right to buy) A-Award	Mather Charles E Iv Director	Director	85 106 Value: $55.3K
Jun 12, 2024 Buy	Common Stock, par value $.0001 A-Award	Jacobson Rachel Director	Director	61 481 Value: $3.20M
Jun 12, 2024 Buy	Stock Option (right to buy) A-Award	Jacobson Rachel Director	Director	85 106 Value: $55.3K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT EYENOVIA INC.

Eyenovia, Inc., a clinical stage ophthalmic company, engages in developing therapeutics based on its proprietary microdose array print platform technology. The company focuses on developing clinical microdosing of formulations of ophthalmic pharmaceutical agents using its Optejet branded targeted ocular delivery system. It focuses on the development of therapeutic indications for patients with progressive myopia and age-related near vision impair...

Read Full Profile Here